https://www.pharmanow.live/latest-news/dr-reddys-gains-brazil-approval-generic-semaglutide-injection-type-2-diabetes 2026-11-07T22:18:27+05:30 Pharma Now en 2026-11-07T00:00:00+05:30 Dr. Reddy's Gains Brazil Approval for Generic Semaglutide Injection Dr. Reddy's https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/6557730b-6b75-4aef-9983-f2a9fa8022b3/ee3dd0ad-ab32-448d-9566-2f7fcfc930ca.png https://www.pharmanow.live/latest-news/janssen-fda-full-approval-erdafitinib-fgfr3-urothelial-carcinoma 2026-11-07T22:24:25+05:30 Pharma Now en 2026-11-07T00:00:00+05:30 Janssen Gains FDA Approval for Erdafitinib in Urothelial Carcinoma Janssen https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/6557730b-6b75-4aef-9983-f2a9fa8022b3/ecd44ed8-8895-4ad7-a731-2211a06c14de.png https://www.pharmanow.live/latest-news/xcovery-holdings-fda-approval-ensartinib-alk-positive-metastatic-nsclc 2026-11-07T22:25:51+05:30 Pharma Now en 2026-11-07T00:00:00+05:30 Xcovery Holdings Gains FDA Approval for Ensartinib in ALK-Positive Metastatic NSCLC FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/6557730b-6b75-4aef-9983-f2a9fa8022b3/9feb7df0-a0d9-4a0e-bcea-fabf295adc46.png https://www.pharmanow.live/latest-news/checkpoint-therapeutics-fda-approval-cosibelimab-ipdl-cscc 2026-11-07T22:27:34+05:30 Pharma Now en 2026-11-07T00:00:00+05:30 Checkpoint Therapeutics Gains FDA Approval for Cosibelimab-ipdl https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/6557730b-6b75-4aef-9983-f2a9fa8022b3/d3a8f2b4-5a66-4218-ac72-f9f02aa83739.png https://www.pharmanow.live/latest-news/janssen-gains-traditional-fda-approval-rybrevant-egfr-exon-20-nsclc 2026-11-07T22:29:10+05:30 Pharma Now en 2026-11-07T00:00:00+05:30 Janssen Gains Traditional FDA Approval for Rybrevant in First-Line EGFR NSCLC Janssen https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/6557730b-6b75-4aef-9983-f2a9fa8022b3/4a18bae1-29ce-46eb-ad69-39fb35d7728a.png https://www.pharmanow.live/latest-news/fda-investigates-insertional-oncogenesis-zolgensma-aav-gene-therapy 2026-11-07T21:52:59+05:30 Pharma Now en 2026-11-07T00:00:00+05:30 FDA Investigates Oncogenesis Cases Linked to Novartis Zolgensma FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/6557730b-6b75-4aef-9983-f2a9fa8022b3/fb7ba439-62a9-4099-a8b0-0ec2fead954b.png https://www.pharmanow.live/latest-news/advanced-accelerator-applications-fda-approval-lutathera-pediatric-gep-nets 2026-11-07T21:59:00+05:30 Pharma Now en 2026-11-07T00:00:00+05:30 FDA Approves Lutathera for Pediatric GEP-NETs Aged 12+ FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/6557730b-6b75-4aef-9983-f2a9fa8022b3/aaa3b0c9-52a8-44e5-8d41-d19a683f20d5.png https://www.pharmanow.live/latest-news/ipsen-fda-approval-onivyde-first-line-metastatic-pancreatic-adenocarcinoma 2026-11-07T22:02:35+05:30 Pharma Now en 2026-11-07T00:00:00+05:30 Ipsen Gains FDA Approval for Onivyde in First-Line Metastatic Pancreatic Adenocarcinoma FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/6557730b-6b75-4aef-9983-f2a9fa8022b3/4caac3f6-5904-420b-ab13-b65847aadd53.png https://www.pharmanow.live/latest-news/pfizer-fda-approval-besponsa-pediatric-all-inotuzumab-ozogamicin 2026-11-07T22:11:18+05:30 Pharma Now en 2026-11-07T00:00:00+05:30 Pfizer Gains FDA Approval for Besponsa in Pediatric Relapsed or Refractory ALL Patients Pfizer https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/6557730b-6b75-4aef-9983-f2a9fa8022b3/570e7530-2e19-4225-b969-ea8d4440cea2.png https://www.pharmanow.live/latest-news/genentech-fda-approval-inavolisib-palbociclib-fulvestrant-pik3ca-breast-cancer 2026-11-07T22:14:38+05:30 Pharma Now en 2026-11-07T00:00:00+05:30 FDA Approves Genentech's Inavolisib Triplet with Companion Diagnostic FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/6557730b-6b75-4aef-9983-f2a9fa8022b3/ce990ff9-a7cd-4dd2-ae1d-2cad40914331.png https://www.pharmanow.live/latest-news/gsk-fda-approval-blenrep-belantamab-mafodotin-relapsed-refractory-multiple-myeloma-dreamm-7 2026-11-07T22:15:53+05:30 Pharma Now en 2026-11-07T00:00:00+05:30 GSK Gains FDA Approval for Blenrep in Relapsed or Refractory Multiple Myeloma GSK https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/6557730b-6b75-4aef-9983-f2a9fa8022b3/e92b3f54-aaf6-45f5-84fb-838d1fd2b58c.png https://www.pharmanow.live/latest-news/janssen-fda-approval-subcutaneous-rybrevant-faspro-nsclc 2026-11-07T22:16:44+05:30 Pharma Now en 2026-11-07T00:00:00+05:30 Janssen Gains FDA Approval for Subcutaneous Rybrevant Faspro Janssen https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/6557730b-6b75-4aef-9983-f2a9fa8022b3/e72a80db-09ed-493a-9017-8ed754a9603f.png https://www.pharmanow.live/latest-news/incyte-fda-approval-axatilimab-csfr-chronic-graft-versus-host-disease 2026-11-07T22:04:44+05:30 Pharma Now en 2026-11-07T00:00:00+05:30 Incyte Gains FDA Approval for Axatilimab-csfr in cGVHD Incyte https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/6557730b-6b75-4aef-9983-f2a9fa8022b3/01594cb4-d8de-4d42-987e-492977ca5c3c.png https://www.pharmanow.live/latest-news/janssen-fda-approval-inlexzo-intravesical-system-bcg-unresponsive-bladder-cancer 2026-11-07T21:45:54+05:30 Pharma Now en 2026-11-07T00:00:00+05:30 Janssen Gains FDA Approval for Inlexzo Intravesical System in Bladder Cancer Janssen https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/6557730b-6b75-4aef-9983-f2a9fa8022b3/cd6dd217-4cf5-4f38-92ab-345edf9f384c.png https://www.pharmanow.live/latest-news/fda-oha-guidance-combination-products-rare-disease-regulatory-expectations 2026-11-07T12:11:07+05:30 Pharma Now en 2026-11-06T00:00:00+05:30 FDA OHA Guidance Agenda Covers Rare Disease and Product Reviews FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/fda-oha-guidance-agenda-combination-products-rare-disease-202620261107121015.webp https://www.pharmanow.live/latest-news/moderna-mrna-ebola-vaccine-phase-2-3-dr-congo 2026-11-07T11:59:29+05:30 Pharma Now en 2026-11-06T00:00:00+05:30 Moderna Achieves Phase 2/3 Recommendation for mRNA Ebola Vaccine Moderna https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/moderna-mrna-1469-ebola-vaccine-phase-2-3-dr-congo-202620261107115827.webp https://www.pharmanow.live/latest-news/maat-pharma-picasso-trial-maat013-metastatic-melanoma-safety-endpoint 2026-11-07T11:53:48+05:30 Pharma Now en 2026-11-06T00:00:00+05:30 MaaT Pharma Achieves Primary Safety Endpoint in PICASSO Trial MaaT https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/maat-pharma-maat013-picasso-trial-metastatic-melanoma-safety-202620261107115329.webp https://www.pharmanow.live/latest-news/fda-2024-anda-approvals-720-generic-pricing-pressure 2026-11-07T11:47:34+05:30 Pharma Now en 2026-11-06T00:00:00+05:30 FDA Reports 720 Generic Approvals Amid Pricing Pressure FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/4f71f6a9-6fa5-4432-9941-fa18c14e970f/ddc780db-85ce-47fe-a1a7-810968a9ddda.png https://www.pharmanow.live/latest-news/rigel-pharmaceuticals-launches-veppanu-first-fda-approved-protac-therapy-metastatic-breast-cancer 2026-11-07T11:43:15+05:30 Pharma Now en 2026-11-06T00:00:00+05:30 Rigel Launches VEPPANU as First FDA-Approved PROTAC Therapy Rigel https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/rigel-veppanu-first-fda-approved-protac-therapy-cmc-quality-202620261107114204.webp https://www.pharmanow.live/latest-news/janssen-fda-accelerated-approval-rybrevant-faspro-hnscc 2026-11-07T11:30:44+05:30 Pharma Now en 2026-11-06T00:00:00+05:30 Janssen Gains FDA Accelerated Approval for Rybrevant Faspro Janssen https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/janssen-rybrevant-faspro-fda-accelerated-approval-hnscc-202620261107112835.webp https://www.pharmanow.live/latest-news/cabaletta-bio-targets-1q28-bla-submission-rese-cel-cart-manufacturing 2026-11-07T11:23:52+05:30 Pharma Now en 2026-11-06T00:00:00+05:30 Cabaletta Bio Targets 1Q28 BLA Submission for Rese-cel Cabaletta https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/cabaletta-rese-cel-bla-submission-car-t-manufacturing-202820261107112216.webp https://www.pharmanow.live/latest-news/allogene-therapeutics-alpha3-enrollment-asia-pacific-expansion-lbcl 2026-11-07T11:08:01+05:30 Pharma Now en 2026-11-06T00:00:00+05:30 Allogene Reports Strong ALPHA3 Enrollment Across Asia-Pacific Allogene https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/allogene-alpha3-trial-asia-pacific-enrollment-lbcl-202620261107110736.webp https://www.pharmanow.live/latest-news/lantheus-merges-curium-8-billion-deal-dual-fda-approvals 2026-11-07T10:57:51+05:30 Pharma Now en 2026-11-06T00:00:00+05:30 Lantheus-Curium $8 Billion Merger Follows Two FDA Approvals Lantheus https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/lantheus-curium-8-billion-merger-dual-fda-approvals-202620261107105714.webp https://www.pharmanow.live/latest-news/fda-launches-rare-disease-framework-initiative-orphan-drug-review 2026-11-07T10:51:27+05:30 Pharma Now en 2026-11-06T00:00:00+05:30 FDA Launches Rare Disease Framework to Reshape Drug Reviews FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/4f71f6a9-6fa5-4432-9941-fa18c14e970f/6d576d78-51ae-4600-a479-fd602da8b870.png